India Globalization Capital, Inc. (IGC)

igcIndia Globalization Capital, Inc operates in several locations around the world to acquire, incubate, finance, and grow companies in various industries. Through its subsidiaries, it has businesses in India, Inner Mongolia, China, Hong Kong, and the United States. Its business lines include iron ore processing, electronic components trading, clean energy, equipment leasing, and vertical farming, and it has entered the marijuana industry as well.

The company’s foray into the legal cannabis industry involves its vertical farming projects in the US. Currently, it is planning to build indoor vertical farms designed to produce organic green vegetables, and eventually, legal marijuana. Also part of the company’s strategy are creating a portfolio of cannabis and hemp-based patents, developing FDA-approved drugs based on cannabinoids, and establishing a cannabis R&D laboratory.

More recently, the multi-national company acquired Midtown Partners & Co, LLC, a New York-based licensed broker-dealer, to expand its marijuana strategy. With Midtown as its subsidiary, IGC will offer capital-raising platforms and broker-dealer services to cannabis businesses. One of the major platforms it plans to build is a crowdfunding site for small to midsize enterprises. Other services will include investment banking and equity research.

The legal marijuana industry is only one of the areas where IGC intends to expand. To minimize its dependence on its iron ore business, its diversification strategy aims for growth in clean technology, solar energy, and specialty pharmaceuticals as well.

India Globalization Capital was incorporated in Maryland in 2005. It now trades in the NYSE MKT with the symbol IGC, and a market cap of USD 8.69 M.

Among the top management executives in the company are Ram Mukunda, CEO, President, and Director; Daniel Ngai, Principal Financial and Accounting Officer; and Belur Ram Kishan, Sunny Tsang, and Amit Dutta, Managing Directors.

Yahoo! Finance: IGC News

Latest Financial News for IGC

India Globalization Capital More Than Doubles Revenue, Posts Q2 Net Loss of $1.32M

India Globalization Capital, Inc . (NYSE: IGC ) reported Wednesday  with second-quarter revenue of $1.8 million, up 125% from the same quarter in 2018, when it posted $810,000 in revenue.  During the quarter, ...

IGC Reports Financial Results for the Quarter Ended September 30, 2019

India Globalization Capital, Inc. today announced financial results for the quarter ended September 30, 2019, which is the second quarter of its 2020 fiscal year.

IGC Opens Marketing and Research Hub in Colombia

India Globalization Capital, Inc. (IGC) announced today that it has opened a marketing and research office in Colombia, South America. Hamsa Biochem SAS, a new beneficially owned subsidiary of IGC, will focus on marketing and research initiatives to advance Hyalolex™, Holi Hemp™, and other products in Latin America and among the greater Hispanic community in the United States, in compliance with applicable law and regulations. Hyalolex™, which is currently available in more than 40 dispensaries in Puerto Rico, is based on a formulation described in a patent filing acquired from the University of South Florida (USF) in 2017, with pre-clinical research that indicates that micro-doses of cannabis, in combination with other natural compounds, may be beneficial to Alzheimer’s cell lines and to memory in transgenic mice.

Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group

NEW YORK , July 26, 2019 /PRNewswire/ --   Amneal Pharmaceuticals, Inc. (AMRX) Lifshitz & Miller  announces investigation into possible securities laws violations in connection with allegations that Amneal ...

Marijuana Penny Stocks: Where Risk Meets Sin

Marijuana producers and users, working in a market that's still illegal in many states, are a risky but promising bet for investors.